7 research outputs found

    Heart Rate Variability in Patients with Post-infarction Left Ventricular Aneurysm

    Get PDF
    The parameters of heart rate variability are known to be widely used for screening the occurrence of ventricular arrhythmia in patients with post-infarction left ventricular aneurysm. However, in literature, there are not much data on changes in heart rate variability in patients with post-infarction left ventricular aneurysm depending on different therapeutic approaches, and this issue is not sufficiently studied.Β The objective of the researchΒ was to study the peculiarities of heart rate variability in patients with post-infarction left ventricular aneurysms depending on therapeutic approach.Materials and methods.Β We analyzed heart rate variability of 238 patients with post-infarction left ventricular aneurysm. All patients were divided into 3 groups depending on therapeutic approach: optimal basic therapy, patients who underwent percutaneous coronary interventions and those after coronary artery bypass grafting. All patients underwent 24-hours standard ECG monitoring with the analysis of heart rate variability.Results.Β The study showed that heart rate variability of patients with post-infarction left ventricular aneurysm depended on treatment tactics; hypersympathicotonia was typical. The values of the low-frequency range in patients of Group I and Group III constituted 3103Β±93.6 ms2Β and 3295Β±45.4 ms2, respectively, which was higher compared to those in the control group and Group II, Ρ€<0.05. Parasympathetic influences in patients with post-infarction left ventricular aneurysm were weakened. The analysis of the integral parameters showed that in patients with post-infarction left ventricular aneurysm the autonomous mechanisms of regulation predominated over the central ones. The centralization index was the lowest in patients of Group I and Group II, 2.9Β±0.3 and 2.3Β±0.1, respectively, being lower compared to the control group, Ρ€<0.05. The other peculiarities were detected as well.Conclusions.Β The parameters of heart rate variability in patients with post-infarction left ventricular aneurysm were found to depend on treatment tactics. The patients with non-surgical treatment tactics had the most unfavorable heart rate variability characteristics. They developed hypersympathicotonia and high humoral regulatory influences. The application of revascularization when treating patients with post-infarction left ventricular aneurysm using percutaneous coronary interventions can reduce the aggressive sympathetic influences, as well as the value of the Baevsky index. Revascularization with the use of coronary artery bypass grafting does not allow optimizing the autonomous imbalance, although it reduces stress index

    ECG Phenomena in Patients with Post-Infarction Left Ventricular Aneurysm

    Get PDF
    The objective of the research was to study the ECG phenomena in patients with post-infarction left ventricular aneurysm (PLVA) depending on the treatment approach.Materials and methods. We analyzed results of 24-hour ECG monitoring of 238 patients with PLVA. The main group was divided into 3 subgroups depending on the treatment approach: patients who were treated with optimal background therapy (OBT), percutaneous coronary interventions (PCI), coronary artery bypass graft (CABG) surgery. All patients underwent 24-hours standard ECG monitoring.Results. Our research showed that 50.0% of patients of the first group had tachycardia. AV-junction conduction problems often were observed in those persons (PQ interval was 179.7Β±8.4 ms, which was significantly higher than in the control group, 149.3Β±5.4 ms, Ρ€<0.05). The longest QT interval was also stated for the first group, 532.4Β±27.3 ms, which was significantly longer than the average values of the control group (438.7Β±24.6 ms) and the second group (460.2Β±20.5 ms) respectively, Ρ€<0.05. Revascularization procedures (in the second and third groups) allowed achieving heart rate (HR) control in 66.1% and 62.5% of patients respectively. Complete right bundle branch block (CRBBB) was the most frequent phenomenon of patients of the third group (47.9%), which was significantly higher than in the patients of the first and control groups. We also detected a high frequency of supraventricular ectopic complexes in patients of the first and the third groups. A percentage of ventricular ectopic beats was the highest in the third group (17.7%).Conclusions. Patients with PLVA tended to have tachycardia, but the use of LV revascularization procedures allowed improvement of heart rate control. The patients were also characterized by a high percentage of impulse conduction in the atria, β€œAV-junction” and His bundle branches and the use of LV revascularization procedures did not improve the mentioned phenomena, and increased the risk of ectopic complexes in some cases (after CABG).Patients with PLVA had significantly prolonged β€œQT-interval” and therefore (along with the frequent disorders of repolarization) increased risk of sudden death. However, the use of LV revascularization (PCI) reduced it significantly

    ΠžΡ†Ρ–Π½ΠΊΠ° якості Тиття Ρ‚Π° ΠΊΠΎΠ³Π½Ρ–Ρ‚ΠΈΠ²Π½ΠΈΡ… здібностСй Ρƒ Ρ…Π²ΠΎΡ€ΠΈΡ… Π· постінфарктними Π°Π½Π΅Π²Ρ€ΠΈΠ·ΠΌΠ°ΠΌΠΈ Π»Ρ–Π²ΠΎΠ³ΠΎ ΡˆΠ»ΡƒΠ½ΠΎΡ‡ΠΊΠ°

    No full text
    A formation of post-infarction left ventricular aneurysm (PLVA) is one of the markers of unfavorable prognosisΒ and one of the leading causes of coronary heart disease mortality [2, 3]. It is believed that half of the cases of ventricularΒ aneurysms involve formation of LV thrombotic masses [5], and this, in turn, may increase the risk of thromboembolismΒ [7], induce subclinical disorders of cognitive abilities and worsen life quality (QOL). That is why we studied in a givenΒ subpopulation of patients QOL and cognitive abilities.Β It was stated that patients with PLVA have worse QOL and decreased cognitive abilities, which to some extent dependΒ on treating strategy. The patients with medicament approach only have the worst QOL. Procedures of LV revascularizationΒ improve QOL, but not enough to achieve the quality of control group.Одной ΠΈΠ· ΠΏΡ€ΠΈΡ‡ΠΈΠ½ смСртности ΠΎΡ‚ Π˜Π‘Π‘ Π΅ΡΡ‚ΡŒ Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ Π² постинфарктном ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ Π°Π½Π΅Π²Ρ€ΠΈΠ·ΠΌΡ‹ Π»Π΅Π²ΠΎΠ³ΠΎ ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠ° (ΠŸΠΠ›Π–) – ΠΌΠ°Ρ€ΠΊΠ΅Ρ€Π°, Π² Π±ΠΎΠ»ΡŒΡˆΠΈΠ½ΡΡ‚Π²Π΅ случаСв, нСблагоприятного ΠΏΡ€ΠΎΠ³Π½ΠΎΠ·Π° [2, 3]. БчитаСтся, Ρ‡Ρ‚ΠΎ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Π° случаСв Π°Π½Π΅Π²Ρ€ΠΈΠ·ΠΌ Π›Π– сопровоТдаСтся тромботичСскими массами [5], Π° это, Π² свою ΠΎΡ‡Π΅Ρ€Π΅Π΄ΡŒ, ΠΌΠΎΠΆΠ΅Ρ‚ ΡƒΠ²Π΅Π»ΠΈΡ‡ΠΈΠ²Π°Ρ‚ΡŒ риск тромбоэмболизма [7], Π° Ρ‚Π°ΠΊΠΆΠ΅ субклиничСских Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½ΠΎΠΉ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ ΠΈ качСства ΠΆΠΈΠ·Π½ΠΈ (ΠšΠ–),Β ΠΈΠ·ΡƒΡ‡Π΅Π½ΠΈΡŽ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π±Ρ‹Π»ΠΎ посвящСно нашС исслСдованиС. По Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌ исслСдования ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, Ρ‡Ρ‚ΠΎ Π±ΠΎΠ»ΡŒΠ½Ρ‹Π΅ с ΠŸΠΠ›Π– ΠΈΠΌΠ΅ΡŽΡ‚ сниТСнныС качСство ΠΆΠΈΠ·Π½ΠΈ ΠΈ ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Π΅ способности, Ρ‡Ρ‚ΠΎ Π² Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ ΠΌΠ΅Ρ€Π΅ зависит ΠΈ ΠΎΡ‚ Π²Ρ‹Π±Ρ€Π°Π½Π½ΠΎΠΉ Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΈ вСдСния Ρ‚Π°ΠΊΠΈΡ… Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…. Π‘Π°ΠΌΠΎΠ΅ Ρ…ΡƒΠ΄ΡˆΠ΅Π΅ ΠšΠ– Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€Π½ΠΎ для Π»ΠΈΡ† с ΠŸΠΠ›Π– ΠΈ ΠΈΡΠΊΠ»ΡŽΡ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½Ρ‚ΠΎΠ·Π½ΠΎΠΉ Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΎΠΉ лСчСния. ИспользованиС процСдур рСваскуляризации Π›Π– позволяСт ΡƒΠ»ΡƒΡ‡ΡˆΠΈΡ‚ΡŒ ΠšΠ–, ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ΅, ΠΏΡ€Π°Π²Π΄Π°, Π½Π΅ достигаСт уровня Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π±Π΅Π· ΠŸΠΠ›Π–.ΠžΠ΄Π½Ρ–Ρ”ΡŽ Π· ΠΏΡ€ΠΈΡ‡ΠΈΠ½ смСртності Π²Ρ–Π΄ Π†Π₯Π‘ є формування Ρƒ постінфарктному ΠΏΠ΅Ρ€Ρ–ΠΎΠ΄Ρ– Π°Π½Π΅Π²Ρ€ΠΈΠ·ΠΌΠΈ Π»Ρ–Π²ΠΎΠ³ΠΎ ΡˆΠ»ΡƒΠ½ΠΎΡ‡ΠΊΠ° (ΠŸΠΠ›Π¨) – Ρƒ Π±Ρ–Π»ΡŒΡˆΠΎΡΡ‚Ρ– Π²ΠΈΠΏΠ°Π΄ΠΊΡ–Π² маркСра нСсприятливого ΠΏΡ€ΠΎΠ³Π½ΠΎΠ·Ρƒ [2, 3]. Π’Π²Π°ΠΆΠ°Ρ”Ρ‚ΡŒΡΡ, Ρ‰ΠΎ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Π° Π²ΠΈΠΏΠ°Π΄ΠΊΡ–Π² Π°Π½Π΅Π²Ρ€ΠΈΠ·ΠΌ Π›Π¨ ΡΡƒΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΆΡƒΡŽΡ‚ΡŒΡΡ Ρ‚Ρ€ΠΎΠΌΠ±ΠΎΡ‚ΠΈΡ‡Π½ΠΈΠΌΠΈ масами [5], Π° Ρ†Π΅, Ρƒ свою Ρ‡Π΅Ρ€Π³Ρƒ, ΠΌΠΎΠΆΠ΅ Π·Π±Ρ–Π»ΡŒΡˆΡƒΠ²Π°Ρ‚ΠΈ Ρ€ΠΈΠ·ΠΈΠΊ Ρ‚Ρ€ΠΎΠΌΠ±ΠΎΠ΅ΠΌΠ±ΠΎΠ»Ρ–Π·ΠΌΡƒ [7], Π° Ρ‚Π°ΠΊΠΎΠΆ ΡΡƒΠ±ΠΊΠ»Ρ–Π½Ρ–Ρ‡Π½ΠΈΡ…Β ΠΏΠΎΡ€ΡƒΡˆΠ΅Π½ΡŒ ΠΊΠΎΠ³Π½Ρ–Ρ‚ΠΈΠ²Π½ΠΎΡ— Ρ„ΡƒΠ½ΠΊΡ†Ρ–Ρ— Ρ‚Π° якості Тиття (Π―Π–),Β Π²ΠΈΠ²Ρ‡Π΅Π½Π½ΡŽ яких Π±ΡƒΠ»ΠΎ присвячСнС нашС дослідТСння. Π—Π° Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌΠΈ дослідТСння виявлСно, Ρ‰ΠΎ особи Π·Β ΠŸΠΠ›Π¨ ΠΌΠ°ΡŽΡ‚ΡŒ Π·Π½ΠΈΠΆΠ΅Π½Ρƒ ΡΠΊΡ–ΡΡ‚ΡŒ Тиття Ρ‚Π° Π½ΠΈΠΆΡ‡Ρ– ΠΊΠΎΠ³Π½Ρ–Ρ‚ΠΈΠ²Π½Ρ– здібності, які Π·Π½Π°Ρ‡Π½ΠΎΡŽ ΠΌΡ–Ρ€ΠΎΡŽ Π·Π°Π»Π΅ΠΆΠ°Ρ‚ΡŒ Ρ‚Π°ΠΊΠΎΠΆ Π²Ρ–Π΄Β ΠΎΠ±Ρ€Π°Π½ΠΎΡ— Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΈ вСдСння Ρ‚Π°ΠΊΠΈΡ… Ρ…Π²ΠΎΡ€ΠΈΡ…. ΠΠ°ΠΉΠ³Ρ–Ρ€ΡˆΠ° Π―Π–Β Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€Π½Π° для осіб Ρ–Π· ΠŸΠΠ›Π¨ Ρ‚Π° Π²ΠΈΠΊΠ»ΡŽΡ‡Π½ΠΎ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½Ρ‚ΠΎΠ·Π½ΠΎΡŽ Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΎΡŽ лікування. Використання процСдур рСваскуляризації дозволяє ΠΏΠΎΠΊΡ€Π°Ρ‰ΠΈΡ‚ΠΈ Π―Π–, яка, ΠΏΡ€ΠΎΡ‚Π΅,Β Π½Π΅ сягає рівня осіб Π±Π΅Π· ΠŸΠΠ›Π¨

    A review of membrane development in membrane distillation for emulsified industrial or shale gas wastewater treatments with feed containing hybrid impurities

    No full text
    corecore